Related Experiment Videos
The multistage model of cancer development: some implications
Gordon Ritter1, Richard Wilson, Francesco Pompei
1Harvard University Department of Physics, Cambridge, MA 02138, USA. ritter@fas.harvard.edu
Toxicology and Industrial Health
|March 8, 2005
Summary
The standard Armitage-Doll multistage model for cancer development cannot explain the sharp drop in cancer incidence after age 80. New models are needed to accurately predict cancer rates in older populations.
Area of Science:
- Epidemiology
- Mathematical Biology
- Oncology
Background:
- The Armitage-Doll multistage model successfully described cancer development but had limitations at older ages.
- Previous studies suggested undercounting or the 'biology of extreme old age' for discrepancies.
- Moolgavkar identified approximation errors in the model as a potential cause.
Purpose of the Study:
- To rigorously evaluate the standard Armitage-Doll multistage model against recent cancer incidence data.
- To investigate multistage processes with varying stage progression rates.
- To explore modifications of the model, including cellular senescence.
Main Methods:
- Mathematical analysis of exact solutions to multistage models.
- Comparison of model predictions with recent cancer incidence data, particularly above age 80.
- Investigation of multistage processes with fast-progressing stages.
Main Results:
- The standard Armitage-Doll model cannot reproduce the rapid decline in cancer incidence observed after age 80.
- Fast-progressing stages in multistage models have minimal impact on overall cancer incidence rates.
- The simplest modification incorporating cellular senescence yields the Pompei-Wilson beta model.
Conclusions:
- The Armitage-Doll model requires significant revision to accurately reflect cancer incidence at advanced ages.
- Understanding stage-specific progression is crucial for cancer modeling and treatment strategies.
- The Pompei-Wilson beta model offers a potential improvement for predicting age-related cancer trends.